Bone turnover markers and bone mineral density in hypertensive postmenopausal women on treatment

Maturitas

Volumn 65, Issue 4, 2010, Pages 396-402

  Olmos, José M ^a   Hernández, José L ^a   Martínez, Josefina ^a   Castillo, Jesús ^b   Valero, Carmen ^a   Pérez Pajares, Isabel ^b   Nan, Daniel ^a   González Macías, Jesús ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

Bone mineral density; Bone turnover markers; Hypertension; Parathyroid hormone; Quantitative ultrasound; Thiazides

Indexed keywords

25 HYDROXYVITAMIN D; AMINO TERMINAL TELOPEPTIDE; ANTIHYPERTENSIVE AGENT; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; PARATHYROID HORMONE; THIAZIDE DIURETIC AGENT; VITAMIN D;

ARTICLE; BONE DENSITY; BONE METABOLISM; BONE TURNOVER; CHEMOLUMINESCENCE; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; ELECTROCHEMICAL ANALYSIS; FEMUR NECK; HYPERTENSION; LUMBAR SPINE; PARATHYROID HORMONE BLOOD LEVEL; POSTMENOPAUSE;

ABSORPTIOMETRY, PHOTON; AGED; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; CALCIUM; FEMALE; HOMEOSTASIS; HUMANS; HYPERTENSION; MIDDLE AGED; POSTMENOPAUSE; THIAZIDES; ULTRASONOGRAPHY;

EID: 77649182184     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2010.01.007     Document Type: Article

References (44)

1. WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical report series 843. Geneva: WHO; 1994.
2. Melton III L.J., Chrischilles E.A., Cooper C., Lane A.W., and Riggs B.L. How many women have osteoporosis?. J Bone Miner Res 7 (1992) 1005-1010
3. Díez A., González-Macías J., Marín F., et al. Prediction of absolute risk of non-spinal fractures using clinical risk factors and heel quantitative ultrasound. Osteoporos Int 18 (2007) 629-639
4. Pérez-Castrillón J.L., Justo I., Sanz-Cantalapiedra A., Pueyo C., Hernández G., and Dueñas A. Effect of the antihypertensive treatment on the bone mineral density and osteoporotic fracture. Curr Hypertens Rev 1 (2005) 61-66
5. Tsuda K., Nistui I., and Masuyama Y. Bone mineral density in women with essential hypertension. Am J Hypertens 14 (2001) 704-707
6. Hanley D.A., Brown J.P., Tenenhause A., et al. Associations between disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: cross-sectional results of the Canadian Multicentre Osteoporosis Study. J Bone Miner Res 18 (2003) 784-790
7. Mussolino M.E., and Gillum R.F. Bone mineral density and hypertension prevalence in postmenopausal women: results from the Third National Health and Nutrition Examination Survey. Ann Epidemiol 16 (2006) 395-399
8. Renjmark L., Vestergaard P., and Mosekilde L. Reduced fracture risk in users of thiazide diuretics. Calcif Tissue Int 76 (2005) 167-175
9. Cauley J.A., Cummings S.R., Seeley D.G., et al. Effects of thiazide diuretic therapy on bone mass, fractures, and falls. The Study of Osteoporotic Fractures Research Group. Ann Intern Med 118 (1993) 666-673
10. Feskanisch D., Willet W.C., Stampfer J.M., and Golditz G.A. A prospective study of thiazide use and fractures in women. Osteoporos Int 7 (1997) 79-84
11. Schoofs M.W., van der Klift M., Hofman A., et al. Thiazide diuretics and the risk for hip fracture. Ann Intern Med 139 (2000) 476-482
12. La Croix A.Z., Wienpahl J., White L.R., et al. Thiazide diuretic agents and the incidence of hip fracture. N Engl J Med 322 (1990) 286-290
13. LaCroix A.Z., Ott S.M., Ichikawa L., Scholes D., and Barlow W.E. Low-dose hydroclorothiazide and preservation of bone mineral density in older adults A randomized, double-blind, placebo-controlled trial. Ann Intern Med 133 (2000) 516-526
14. Bolland M.J., Ames R.W., Horne A.M., Orr-Walker B.J., Gamble G.D., and Reid I.R. The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women. Osteoporos Int 18 (2007) 479-486
15. Wasnick R.D., Davis J., Ross P., and Vogel J. Effect of thiazide on rates of bone mineral loss: a longitudinal study. Br Med J 301 (1990) 1303-1305
16. Sigurdson G., and Franzson L. Increased bone mineral density in a population-based group of 70-year-old women on thiazide diuretics, independent of parathyroid hormone levels. J Intern Med 250 (2001) 51-56
17. Rejnmark L., Vestergaard P., Heickendorff L., Adreansen F., and Mosekilde L. Effects of thiazide- and loop-diuretics, alone or in combination, on calciotropic hormmones and biochemical bone markers: a randomized controlled study. J Intern Med 250 (2001) 144-153
18. Reid I.R., Ames R.W., Orr-Walker B.J., et al. Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial. Am J Med 109 (2000) 362-370
19. van Daele P.L., Burguer H., Algra D., et al. Age-associated changes in ultrasound measurements of the calcaneus in men and women: the Rotterdam Study. J Bone Miner Res 9 (1994) 1751-1757
20. Transbol I., Christensen M.S., Jensen G.F., Christiansen C., and McNair P. Thiazide for the postponement of postmenopausal bone loss. Metabolism 31 (1982) 383-386
21. Bauer D.C., Browner W.S., Cauley J.A., et al. Factors associated with appendicular bone mass in older women. The Study of Osteoporotic Fractures Research Group. Ann Intern Med 118 (1993) 657-665
22. Reusz G.S., Dobos M., Vasarhely B., et al. Sodium transport and bone mineral density in hypercalciuria with thiazide treatment. Pediatr Nephrol 12 (1998) 30-34
23. Middler S., Pack C.Y., Murad F., and Bartter F.C. Thiazide diuretics and calcium metabolism. Metabolism 22 (1973) 139-146
24. Nowack R., Hofner M.C., Reichel H., Schmidt Gayk H., and Ritz E. Subacute effects of thiazide administration on renal hemodynamics and calcium metabolism. Clin Invest 70 (1992) 689-691
25. Lemann J.J., Gray R.W., Malerhofer W.J., and Cheung H.S. Hydrochlorothiazide inhibits bone resorption in men despite experimentally elevated serum 1,25-dihydroxyvitamin D concentrations. Kidney Int 28 (1985) 951-958
26. Lalande A., Roux S., Denne M.A., et al. Indapamide, a thiazide diuretic decrease bone resorption in vitro. J Bone Miner Res 16 (2001) 361-370
27. Berry E.M., Gupta M.M., Turner S.J., and Burns R.R. Variations in plasma calcium with induced changes in plasma specific gravity, total protein, and albumin. Br Med J IV (1973) 640-643
28. Garnero P., Vergnaud P., and Hoyle N. Evaluation of a fully automated serum assay for total N-terminal propeptide of type I collagen in postmenopausal osteoporosis. Clin Chem 54 (2008) 188-196
29. Garnero P., Borel O., and Delmas P.D. Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis. Clin Chem 47 (2001) 694-702
30. Riancho J.A., Valero C., Hernández J.L., et al. Biomechanical indices of the femoral neck estimated from the Standard DXA output: age- and sex-related differences. J Clin Densitomet 10 (2007) 39-45
31. Alenfeld F.M., Engelke K., Schmidt T., Bredzger M., Diessel E., and Felsenberg D. Diagnostic agreement of two calcaneal ultrasound devices: the Sahara bone sonometer and the Achilles+. Br J Radiol 75 (2002) 895-902
32. Sosa M., Saavedra P., Muñoz M., et al. Quantitative ultrasound calcaneus measurements: normative data and precision in the Spanish population. Osteoporos Int 13 (2002) 487-492
33. Cappuccio F.P., Meihlan E., Zmuda J.M., and Cauley J.A. High blood pressure and bone mineral loss in elderly white women: a prospective study. Lancet 354 (1999) 971-975
34. Kamel H.K. Low-dose thiazide and bone density. Lancet 136 (2002) 252-253
35. Ott S.M., La Croix A.Z., Scholles D., Ichikawa L.E., and Wu K. Effects of three years of low-dose thiazides on mineral metabolism in healthy elderly persons. Osteoporos Int 19 (2008) 1315-1322
36. Wasnick R.D., Davis J.W., He Y.F., Petrovic H., and Ross P.D. A randomized, double-masked, placebo-controlled trial of chlortalidone and bone loss in elderly women. Osteoporos Int 5 (1995) 247-251
37. Peh C.A., Horowitz M., Wishart J.M., Need A.G., Morris H.A., and Nordin B.E. The effect of chlorothiazide on bone-related biochemical variables in normal postmenopausal women. J Am Geriatr Soc 41 (1993) 513-516
38. Sun J., Elwood W., Barnes P.J., and Chung K.F. Effect of thiazide diuretics against neurally mediated contraction of guinea pig airways: contribution of carbonic anhydrase. Am Rev Respir Dis 148 (1993) 902-908
39. Pierce W.M., Nardin G.F., Fuqua M.F., Sabah-Maren E., and Stern S.H. Effect of chronic carbonic anhydrase inhibitor therapy on bone mineral density in white women. J Bone Miner Res 6 (1991) 347-354
40. Steiniche T., Mosekilde L., Christensen M.S., and Melsen F. Histomorphometric analysis of bone in idiopatic hypercalciuria before and after treatment with thiazides. APMIS 97 (1989) 302-308
41. Pérez Castrillón J.L., Justo I., Silva J., et al. Bone mass and bone modelling markers in hypertensive postmenopausal women. J Hum Hypertens 17 (2003) 107-110
42. Barry E.L., Gesek F.A., Kaplan M.R., Herbert S.C., and Friedman P.A. Expression of the sodium-chloride cotransporter in osteoblast-like cells: effect of thiazide diuretics. Am J Physiol 272 (1997) C109-C116
43. Lajeunesse D., Menard P., Morceau R., and Hamel L. Direct effects of thiazides on the human osteosarcoma cell line MG-63. J Bone Miner Res 9 (1994) S355
44. Yamamoto M., Yamaguchi T., Yamauchi M., Yano S., and Sugimoto T. Serum pentosidine levels are positively associated with the presence of vertebral fractures on postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab 93 (2008) 1013-1019